•The Japanese government is considering a controversial plan to intervene in the oil futures market by building short positions using its $1.4 trillion foreign exchange reserves.
•The USD/JPY exchange rate has breached the 160 level, a threshold that previously triggered Bank of Japan interventions.
•The strategy aims to dampen global oil prices, thereby reducing the demand for US dollars needed to fund Japan's energy imports and easing pressure on the yen.
•The US Court of Appeals for the Second Circuit released its decision regarding Burford's Petersen and Eton Park claims against the Republic of Argentina and YPF.
•The case involves multi-billion dollar legal claims arising from the nationalization of the Argentine oil company YPF.
•Wall Street analysts issued a series of research calls (upgrades and downgrades) for major companies including Honeywell, Wix.com, and Emerson Electric.
•The stock market is facing a potential fifth consecutive week of losses amid increased volatility.
•Current market trends are influenced by geopolitical tensions and rising commodity prices as the first quarter concludes.
•Motorola Solutions Canada Networks Inc. entered a definitive agreement to acquire Bell Canada’s land mobile radio networks services business for CAD $675 million.
•The transaction is expected to close in the fourth quarter of 2026, subject to regulatory and third-party approvals.
•The acquisition aims to strengthen the resiliency and security of Canada's land mobile radio communications.
•The U.S. Patent and Trademark Office (USPTO) reaffirmed its prior decision favoring the Broad Institute regarding CRISPR/Cas9 patents.
•The legal dispute was between the Broad Institute (licensor to Editas) and the CVC group, including the University of California and Emmanuelle Charpentier.
•The decision pertains to the use of CRISPR/Cas9 gene editing technology in human cells (eukaryotes).
•ADMA Biologics issued a formal statement refuting Culper Research's allegations, calling them unsubstantiated and misleading.
•The company claims Culper Research misunderstood the competitive position of ASCENIV and the company's role in providing therapies for immune-compromised patients.
•BMO Capital Markets initiated coverage on Honeywell (HON) with an 'Outperform' rating and a $273 price target, suggesting a 21% potential upside.
•Emerson Electric (EMR) was assigned a 'Market Perform' rating with a $150 price target, despite strong quarterly results and positive FY2026 guidance.
•Dover (DOV) earned a 'Market Perform' rating and a $237 price target following a beat on quarterly earnings and revenue estimates.
•The U.S. Department of Justice has sent subpoenas as part of an antitrust investigation into the Paramount-Skydance acquisition of Warner Bros Discovery.
•Japan's Ministry of Health, Labour and Welfare approved Regeneron and Sanofi's Dupixent for treating adults with moderate-to-severe bullous pemphigoid.
•The approval was based on positive data from the LIBERTY-BP-ADEPT Phase 2/3 clinical trial.
•Barclays initiated coverage on Regeneron with an Overweight rating and a $923 price target.
•Sherwin-Williams (SHW) shares fell nearly 12% due to investor concerns over rising oil prices and their impact on production costs.
•The company's management indicated they may be forced to raise prices if raw material costs continue to climb as a result of the Middle East conflict.
•The situation highlights the vulnerability of paint manufacturers to geopolitical events affecting commodity prices.
•Entergy signed an agreement with Meta Platforms expected to generate approximately $2 billion in savings for Entergy Louisiana customers over 20 years.
•The partnership involves significant energy infrastructure expansion, including new natural gas plants and transmission lines.
•Meta will provide funding and support for renewable energy projects as part of the agreement.
